Lamisil and Prilosec otc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamisil and Prilosec otc. Common interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Lamisil and Prilosec otc have. It is created by eHealthMe based on reports of 48 people who take Lamisil and Prilosec otc from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 01, 2022

48 people who take Lamisil and Prilosec otc together, and have interactions are studied.


What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 13,646 Lamisil users for its effectiveness, alternative drugs and more.

What is Prilosec otc?

Prilosec otc has active ingredients of omeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 37,256 Prilosec otc users for its effectiveness, alternative drugs and more.

Number of Lamisil and Prilosec otc reports submitted per year:

Lamisil and Prilosec otc drug interactions.

Common Lamisil and Prilosec Otc drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Renal disorder
  3. Renal failure
  4. Renal impairment
  5. Death
  6. Nephrogenic anaemia
  7. Hypertension
  8. Hypocalcaemia
  9. Hypokalaemia
  10. Renal injury

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Renal tubular necrosis
  4. Urticaria
  5. Death
  6. Drug hypersensitivity
  7. Nephropathy
  8. Nephropathy toxic
  9. Depression
  10. Liver disorder

Common Lamisil and Prilosec Otc drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Hypertension
  3. Hypocalcaemia
  4. Hypokalaemia

30-39:

  1. Chronic kidney disease
  2. Renal injury
  3. Renal failure
  4. Renal impairment

40-49:

  1. Chronic kidney disease
  2. Renal failure
  3. Renal tubular necrosis
  4. Nephropathy toxic
  5. Tubulointerstitial nephritis

50-59:

  1. Renal failure
  2. Fall
  3. Groin pain
  4. Haematoma
  5. Tubulointerstitial nephritis
  6. Urticaria
  7. Death
  8. Drug hypersensitivity
  9. Nephropathy
  10. Renal injury

60+:

  1. Chronic kidney disease
  2. Depression
  3. Liver disorder
  4. Renal disorder
  5. Renal impairment
  6. Renal failure
  7. Death
  8. Nephrogenic anaemia
  9. Renal injury

Common conditions people have *:

  1. High Blood Cholesterol: 16 people, 33.33%
  2. Pain: 15 people, 31.25%
  3. High Blood Pressure: 15 people, 31.25%
  4. Diabetes: 14 people, 29.17%
  5. Infection: 9 people, 18.75%
  6. Breathing Difficulty: 7 people, 14.58%
  7. Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 12.50%
  8. Neuralgia (pain in one or more nerves): 6 people, 12.50%
  9. Depression: 6 people, 12.50%
  10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and Prilosec otc?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Lamisil and Prilosec otc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lamisil interactions:

Browse all interactions between Lamisil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prilosec otc interactions:

Browse all interactions between Prilosec otc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride and omeprazole magnesium (the active ingredients of Lamisil and Prilosec otc, respectively), and Lamisil and Prilosec otc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lamisil and Prilosec otc.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: